Format

Send to

Choose Destination
Med Devices (Auckl). 2018 Mar 1;11:57-63. doi: 10.2147/MDER.S158944. eCollection 2018.

ebb® Complete Tamponade System: effective hemostasis for postpartum hemorrhage.

Author information

1
Clinical Innovations, Salt Lake City, UT, USA.
2
Independent Clinical Consultant, San Francisco, CA, USA.
3
Monmouth Medical Center, Long Branch, NJ, USA.

Abstract

As a leading cause of maternal death, postpartum hemorrhage (PPH) remains a worldwide obstetrical problem. However, in most cases, mortality and morbidity can be averted if efforts are immediately undertaken to achieve hemostasis. Uterine balloon tamponade has been shown to provide effective control of PPH and avoid more invasive surgical procedures and even the emergency peripartum hysterectomy. Recent clinical recommendation suggests that balloon tamponade should be considered earlier in the treatment cascade in conjunction with uterotonic agents to ensure hemostasis in the most timely fashion and maximize clinical outcomes. This paper profiles the ebb® Complete Tamponade System, a unique dual-balloon single-use device that was developed specifically for hemostatic management of PPH. The ebb system combines a uterine conforming balloon that can be rapidly deployed with a vaginal balloon that eliminates the need for vaginal packing. The description, indications for use, procedural steps, and clinical characterization of this device are presented.

KEYWORDS:

balloon tamponade; hemostasis; maternal bleeding; postpartum hemorrhage

Conflict of interest statement

Disclosure RWM is an employee of and JEB is an independent advisor to Clinical Innovations (Salt Lake City, UT, USA). The authors report no other conflicts of interest in this work.

Publication type

Publication type

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center